Company News
Bioscibex has been selected for the BioTools Innovator 2026 Accelerator and VANGUARD cohort, joining top life science tools and diagnostics companies from a highly competitive applicant pool.
Bioscibex has been selected for the BioTools Innovator 2026 Accelerator, joining a group of 30 life science tools and diagnostics companies recognized for their potential to address critical challenges in research, diagnosis, treatment, and biomanufacturing.
The 2026 cohort was chosen from a highly competitive pool of nearly 550 applicants, representing the top 5% of companies considered for the program. Over four months, participating startups will receive tailored mentorship from senior industry leaders, access to funding opportunities, and engagement with a broad network of peers, advisors, and strategic partners.
Bioscibex was selected in the Bioprocessing & Biomanufacturing Tools category and has also been named to the VANGUARD Accelerator track, a joint initiative between BioTools Innovator and BARDA, the Biomedical Advanced Research and Development Authority (part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, to support startups in deploying innovative medical countermeasures that enhance the U.S.’ readiness for public health emergencies). The VANGUARD track supports startups developing technologies with potential relevance to public health preparedness and medical countermeasure readiness.
Through the program, Bioscibex will take part in structured mentorship, industry engagement, and strategic guidance designed to support the company’s development and path to market. VANGUARD companies will also receive additional support to explore how their innovations may align with BARDA’s health security mission.
The BioTools Innovator 2026 cohort will convene at the Innovator Summit from June 2–4 in San Francisco, bringing together accelerator companies, mentors, partners, alumni, and industry leaders from across the life science tools and medical technology ecosystem.
For Bioscibex, this selection marks an important recognition of the company’s work in bioprocessing and biomanufacturing tools, and an opportunity to engage with one of the leading accelerator programs dedicated to advancing life science innovation.
BioTools Innovator is an accelerator based in Los Angeles focused on life science tools and diagnostics startups. The program connects early-stage and emerging growth companies with industry leaders, mentors, advisors, and strategic partners to help accelerate the development and commercialization of technologies that can improve human health.
Read the complete article on Business Wire.
